Expression of recombinant Hirudin in transgenic mice milk driven by the goat beta-casein promoter |
| |
Authors: | Yen Chon-Ho Yang Chi-Kai Chen I-Chung Lin Yin-Shen Lin Chih-Sheng Chu Sen Tu Ching-Fu |
| |
Affiliation: | Division of Biotechnology, Animal Technology Institute Taiwan, Chunan, Miaoli, Taiwan, R.O.C. |
| |
Abstract: | Hirudin, isolated from the leech Hirudo medicinalis, inhibits thrombin directly and several expression systems have been used to produce recombinant Hirudin (rHirudin) for pharmaceutical purposes. A DNA fragment containing the Hirudin coding sequence and goat beta-casein secretion signal was chemically synthesized in this study. The synthetic DNA then was further constructed into a goat beta-casein expression vector for mouse transgenesis. Four lines of transgenic mice were successfully developed and one line showed a meaningful anti-thrombin activity of 40,000 anti-thrombin units (ATU)/mL in their milk. In this animal line, Hirudin mRNA was found in samples of uterus and kidney with insignificant anti-thrombin activity (= 280 ATU/g wet tissue); however, mammary glands showed a higher activity of 780 ATU/g wet tissue. Transgenic mice showed no evident physical abnormality. The purified rHirudin was further analyzed by amino acid analysis and was found to contain a tyrosine O-sulfate residue that is absent in rHirudin expression either through Escherichia coli or yeast host systems. Experimental results demonstrated that the beta-casein-promoted Hirudin transgene could be successfully expressed in a murine model and may be applicable to large mammals such as livestock for mass production of rHirudin for pharmaceuticals. |
| |
Keywords: | Transgenic mice Goat β-casein promoter Hirudin Tyrosine sulfate |
本文献已被 PubMed 等数据库收录! |
|